Literature DB >> 10622572

Hepatitis C and alcohol.

F Degos1.   

Abstract

A close relationship and possible interaction has been noted between alcohol intake and hepatitis C virus infection, since the discovery of HCV markers. It is not understood whether these are additive or synergistic effects in causing liver injury. Interactions between alcohol and HCV may be studied at several levels, including epidemiology, virology (including viral load), histology (effect on the severity of liver lesions), carcinogenesis (the role of alcohol in the occurrence of hepatocellular carcinoma), and the effect on the extrahepatic manifestations or severity of HCV infection. At the epidemiological level, a high prevalence of HCV infection was noted in patients with alcoholic liver diseases (14-37%), also characterized by a high rate of viral replication as detected by PCR, which was present in over 90% of patients tested. Moreover, the prevalence of anti-HCV antibodies increased proportionally with the severity of liver lesions. Virological analysis based on the determination of HCV RNA levels in the serum showed variations of HCV RNA levels with diet, and a clear relationship between self reported alcohol consumption and the levels of serum HCV RNA (r = .26, p = .001). At the histologic level the role of alcohol may be evaluated either through the development of fibrosis or by determination of the incidence of cirrhosis. A study on the effect of alcohol intake below or over 40 g per day on the histologic progression of liver lesions has confirmed a more rapid increase in fibrosis and a doubling in the incidence of cirrhosis in patients admitting to alcohol consumption >40 g per day. The role of alcohol in the occurrence of hepatocellular carcinoma in patients with cirrhosis due to HCV infection has been extensively studied with controversial results. A recent case control study performed in Italy showed that the relative risk of HCC in patients with HCV infection and heavy alcohol consumption doubled. Finally, alcohol consumption potentially worsens the evolution of dermatological diseases associated with HCV infection such as porphyria cutanea tarda. All of the above are strong arguments which should be used to advise HCV patients against alcohol consumption, regardless of the degree of liver injury. However, the deleterious effect of the occasional intake of small amounts of alcohol has not been demonstrated and therefore an occasional drink may be allowed in some cases.

Entities:  

Mesh:

Year:  1999        PMID: 10622572     DOI: 10.1016/s0168-8278(99)80386-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 2.  Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages.

Authors:  M I Prince; M Hudson
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

Review 3.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Liver transplantation for alcoholic liver disease.

Authors:  Vibha Varma; Kerry Webb; Darius F Mirza
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

5.  Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.

Authors:  W N Southern; M-L Drainoni; B D Smith; C L Christiansen; D McKee; A L Gifford; C M Weinbaum; D Thompson; E Koppelman; S Maher; A H Litwin
Journal:  J Viral Hepat       Date:  2010-05-20       Impact factor: 3.728

6.  Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase.

Authors:  Z Q Zhou; D Manguino; K Kewitt; G W Intano; C A McMahan; D C Herbert; M Hanes; R Reddick; Y Ikeno; C A Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

7.  Physician nonadherence with a hepatitis C screening program.

Authors:  William N Southern; Mari-Lynn Drainoni; Bryce D Smith; Elisa Koppelman; M Diane McKee; Cindy L Christiansen; Allen L Gifford; Cindy M Weinbaum; Alain H Litwin
Journal:  Qual Manag Health Care       Date:  2014 Jan-Mar       Impact factor: 0.926

Review 8.  Cocarcinogenic effects of alcohol in hepatocarcinogenesis.

Authors:  F Stickel; D Schuppan; E G Hahn; H K Seitz
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Increase in alcohol related deaths: is hepatitis C a factor?

Authors:  J A Henry; C Moloney; C Rivas; R D Goldin
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

10.  Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.

Authors:  Ke-Qin Hu; Huiying Yang; Ying-Chao Lin; Karen L Lindsay; Allan G Redeker
Journal:  Int J Med Sci       Date:  2004-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.